Elixinol Wellness Ltd
ASX:EXL

Watchlist Manager
Elixinol Wellness Ltd Logo
Elixinol Wellness Ltd
ASX:EXL
Watchlist
Price: 0.009 AUD -10% Market Closed
Market Cap: 2.5m AUD
Section:
 

Relative Value

EXL doesn't have a meaningful market cap.

The Relative Value of one EXL stock under the Base Case scenario is 0.06 AUD. Compared to the current market price of 0.009 AUD, Elixinol Wellness Ltd is Undervalued by 85%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EXL Relative Value
Base Case
0.06 AUD
Undervaluation 85%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
92
vs Industry
72
Median 3Y
1.1
Median 5Y
3.9
Industry
1.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-3
Industry
17.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-4.8
Industry
11.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.3
Industry
15.5
More Details
0.4
P/B
P/B
Price to Book Value
0.4
vs History
82
vs Industry
70
Median 3Y
1.5
Median 5Y
3.2
Industry
1.6
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
79
vs Industry
72
Median 3Y
1
Median 5Y
3.7
Industry
1.2
More Details
0.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.7
vs History
73
vs Industry
75
Median 3Y
2.4
Median 5Y
7.9
Industry
3.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-3.2
Industry
10.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-1.9
Median 5Y
-3.2
Industry
13.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-4.4
Industry
12.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-4.3
Industry
15.6
More Details
0.3
EV/IC
EV/IC
Enterprise Value to IC
0.3
vs History
71
vs Industry
73
Median 3Y
1.2
Median 5Y
3
Industry
1.2
More Details

Multiples Across Competitors

EXL Competitors Multiples
Elixinol Wellness Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Elixinol Wellness Ltd
ASX:EXL
2.5m AUD 0.2 -1.2 -0.8 -0.8
FR
L'Oreal SA
PAR:OR
199.2B EUR 4.5 32.5 18.9 23
UK
Unilever PLC
LSE:ULVR
119B GBP 2.2 23.7 202.1 234.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 8.4 49.5 35.9 39.7
UK
HALEON PLC
LSE:HLN
32.9B GBP 2.9 23 13.8 15.7
US
Estee Lauder Companies Inc
NYSE:EL
37.6B USD 2.6 -39.9 20.5 33.9
DE
Beiersdorf AG
XETRA:BEI
20.6B EUR 2.1 23.4 11.5 14.7
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.6 11.2 17.3
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 8 65.5 40.7 44.6
MY
Bioalpha Holdings Bhd
KLSE:BIOHLDG
28.1m MYR 1.1 -0.7 -0.5 -0.3
IN
Dabur India Ltd
NSE:DABUR
881.2B INR 6.9 48.7 36.5 45.2
P/E Multiple
Earnings Growth PEG
AU
Elixinol Wellness Ltd
ASX:EXL
Average P/E: 36.2
Negative Multiple: -1.2 		N/A N/A
FR
L'Oreal SA
PAR:OR
32.5
8%
4.1
UK
Unilever PLC
LSE:ULVR
23.7
13%
1.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
49.5
8%
6.2
UK
HALEON PLC
LSE:HLN
23
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -39.9 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
23.4
8%
2.9
JP
Kao Corp
TSE:4452
23.6
12%
2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
65.5
19%
3.4
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -0.7 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
48.7
12%
4.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Elixinol Wellness Ltd
ASX:EXL
Average EV/EBITDA: 43.5
Negative Multiple: -0.8 		N/A N/A
FR
L'Oreal SA
PAR:OR
18.9
5%
3.8
UK
Unilever PLC
LSE:ULVR
202.1
2%
101.1
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
35.9
8%
4.5
UK
HALEON PLC
LSE:HLN
13.8
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
20.5
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.5
-1%
N/A
JP
Kao Corp
TSE:4452
11.2
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
40.7
13%
3.1
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -0.5 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
36.5
11%
3.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Elixinol Wellness Ltd
ASX:EXL
Average EV/EBIT: 52.1
Negative Multiple: -0.8 		N/A N/A
FR
L'Oreal SA
PAR:OR
23
6%
3.8
UK
Unilever PLC
LSE:ULVR
234.8
2%
117.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.7
9%
4.4
UK
HALEON PLC
LSE:HLN
15.7
4%
3.9
US
Estee Lauder Companies Inc
NYSE:EL
33.9
25%
1.4
DE
Beiersdorf AG
XETRA:BEI
14.7
-1%
N/A
JP
Kao Corp
TSE:4452
17.3
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
44.6
13%
3.4
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -0.3 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
45.2
11%
4.1

See Also

Summary
EXL intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXL stock valuation using valuation multiples.
Wall Street Estimates
EXL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.